easing the impact of a common neurological disease.
By the Numbers
While migraines are one of the world’s most common health conditions, people living with this disease know that no two migraine experiences are the same. In fact, a migraine is a complex and debilitating group of symptoms unique to you.
Most common disease in the world.
More common in
women than men.
Men, women,
and children impacted.
The Why
Thanks to the commitment and collaboration of researchers and clinical research volunteers, the FDA has approved new preventative treatments that are helping patients achieve more migraine-free days and get back to their daily lives.
Results
- Emgality migraine prevention approved September 2018
- Qulipta for episodic migraines approved September 2021
Interested in joining a trial?